JACQUELINE IANNACONE: Open Payments
NPI 1316675531 · MANASQUAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 63 payments from 13 companies in 2025. Trend: 2023 $1,291 · 2024 $1,017 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $198 |
| Axsome Therapeutics, Inc. | 6 | $177 |
| Alkermes, Inc. | 9 | $164 |
| Lundbeck LLC | 11 | $139 |
| ABBVIE INC. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Bausch Health US, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
Products named: REXULTI, CAPLYTA, Auvelity, ARISTADA, VRAYLAR, LYBALVI, TRINTELLIX, FANAPT.
Industry payments across NJ — which companies pay providers there.
